P. Pétrossians

发表

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

P. Chanson, A. Beckers, A. Daly, 2005, European journal of endocrinology.

The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency

V. Bours, O. Malaise, C. Fasquelle, 2023, Journal of clinical medicine.

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa

V. Bours, V. Dideberg, L. Rostomyan, 2021, Endocrine connections.

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

P. Chanson, M. Jaffrain-Rea, G. Stalla, 2017, Endocrine-related cancer.

Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.

P. Chanson, J. Bertherat, F. Borson‐Chazot, 2017, European journal of endocrinology.

Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism

D. Mazzatenta, G. Trivellin, V. Raverot, 2024, Frontiers in endocrinology.

Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.

F. Faucz, J. Tena, C. Stratakis, 2022, American journal of human genetics.

History of the identification of gigantism and acromegaly

L. Rostomyan, A. Beckers, P. Petrossians, 2021 .

Gigantism: clinical diagnosis and description

L. Rostomyan, A. Beckers, A. Daly, 2021 .

The causes and consequences of pituitary gigantism

A. Beckers, J. Hanson, A. Daly, 2018, Nature Reviews Endocrinology.

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

P. Chanson, V. Bours, J. Bertherat, 2015, Endocrine-related cancer.

X-linked acrogigantism syndrome: clinical profile and therapeutic responses.

J. Lupski, F. Faucz, Jacques Young, 2015, Endocrine-related cancer.

GENETICS IN ENDOCRINOLOGY: Somatic and germline mutations in the pathogenesis of pituitary adenomas.

A. Beckers, S. Vandeva, S. Zacharieva, 2019, European journal of endocrinology.

Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

V. Bours, M. Jaffrain-Rea, A. Beckers, 2011, Expert review of endocrinology & metabolism.

The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.

Didier Martin, A. Beckers, M. Tichomirowa, 2012, Annales d'endocrinologie.

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

T. Arzberger, U. Pagotto, G. Stalla, 2009, International journal of cancer.

Familial Acromegaly: Case Report and Review of the Literature

B. Teh, A. Verloes, A. Beckers, 1999, Pituitary.

Association between mixture of persistent organic pollutants and thyroid pathologies in a Belgian population.

C. Pirard, C. Charlier, A. Beckers, 2019, Environmental research.

The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene

M. Jaffrain-Rea, A. Barlier, A. Karhu, 2023, Frontiers in endocrinology.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

V. Bours, A. Soto-Moreno, A. Beckers, 2019, Endocrine connections.

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients.

P. Chanson, P. Caron, M. Jaffrain-Rea, 2012, European journal of endocrinology.

Familial pituitary tumor syndromes.

A. Beckers, S. Zacharieva, A. Daly, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

R. Paschke, L. Aaltonen, P. Chanson, 2010, The Journal of clinical endocrinology and metabolism.

Mutations and Pituitary Adenomas: An International Collaborative Study AIP Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line

R. Paschke, L. Aaltonen, P. Chanson, 2010 .

Gonadotropin-Secreting Tumors

A. Beckers, A. Daly, H. Valdés-Socin, 2004 .

AUTHOR COPY ONLY

A. Tabarin, V. Bours, J. Urban, 2011 .

Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

A. Beckers, P. Petrossians, A. Thonnard, 2010, Neuroendocrinology.

Extensive inflammatory pseudotumor of the pituitary.

P. Flandroy, K. Kovacs, P. Piguet, 2001, The Journal of clinical endocrinology and metabolism.

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.

C. Raftopoulos, J. Mockel, B. Velkeniers, 1999, The Journal of clinical endocrinology and metabolism.

Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

P. Lancellotti, J. Magne, A. Beckers, 2016, Endocrine.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

R. Dale, R. Mains, S. Stojilkovic, 2023, Frontiers in Endocrinology.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

R. Dale, R. Mains, F. Faucz, 2023, medRxiv.

Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database

P. Chanson, A. Colao, A. Beckers, 2020, Endocrine.

Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.

P. Chanson, V. Rohmer, F. Borson‐Chazot, 2011, European journal of endocrinology.

Multivariable prediction model for biochemical response to first-generation somatostatin receptor ligands in acromegaly.

P. Chanson, M. Jaffrain-Rea, G. Stalla, 2020, The Journal of clinical endocrinology and metabolism.

Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.

I. Lancranjan, P. Flandroy, T. Stadnik, 1992, The Journal of clinical endocrinology and metabolism.